LiCShenYXuR. Evaluation of preprocedural laboratory parameters as predictors of drug-eluting stent restenosis in coronary chronic total occlusion lesions. Angiology. 2019; 70(3): 272–8.
2.
KornowskiRHongMKTioFOBramwellOWuHLeonMB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224–30.
3.
YilmazSAkbogaMKSenF. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10:959–66.
4.
AkbogaMKYalcinRSahinarslanA. Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol. 2016;224:323–7.
5.
YilmazSAkbogaMKArasDTopalogluS. Evaluation of the predictive value of CHA(2)DS(2)-VASc score for in-stent restenosis. Angiology. 2018;69:38–42.
6.
KocasCAbaciOKocasBB. Impact of statin non-adherence on in-stent restenosis following bare-metal stent implantation. Int J Cardiol. 2016;203:529–31.
